凯德尼产品获国家级认可,助力慢性肾病数字化防治
2023年1月,中国疾病预防控制中心慢性非传染性疾病预防控制中心与中国信息通信研究院联合公布《慢性病防治典型数字产品(服务)目录(2022年)》。北京凯德尼医疗科技有限公司自主研发的"凯德尼慢性肾脏病全病程管理系统及数字疗法"成功入选展示目录,成为肾病管理领域的代表性数字产品,获得国家级权威认可。
严格评审,层层筛选
本次评选活动由国家卫生健康委员会、工业和信息化部指导,中国疾病预防控制中心慢性非传染性疾病预防控制中心和中国信息通信研究院共同组织实施,是首批国家级慢性病防治数字产品与服务的权威评选。
评选过程历时数月,经过形式审查、网上初评、网上答辩、技术测试、专家评审、现场考察、公众满意度调查等多个严格环节。最终从全国众多申报产品中,遴选出206个产品和服务,其中82个产品和服务入选"展示目录",124个入选"入围目录"。
凯德尼慢性肾脏病全病程管理系统能够从众多竞争者中脱颖而出,进入展示目录,充分体现了产品在技术创新、临床应用、用户满意度等多个维度的综合优势。
全病程管理,科技赋能肾病防治
"凯德尼慢性肾脏病全病程管理系统及数字疗法"是一套基于互联网、大数据、人工智能技术的智慧医疗解决方案,涵盖慢性肾病的筛查、诊断、治疗、康复、随访等全病程管理环节。
系统采用循证医学理念,所有管理方案和健康建议均基于国内外权威临床指南和最新研究成果,确保医疗服务的专业性和科学性。
临床验证,效果显著
凯德尼慢性肾脏病全病程管理系统自推出以来,已在全国多家三甲医院和基层医疗机构应用,服务超过200万慢性肾病患者,积累了丰富的临床应用经验和真实世界数据。
临床数据显示,使用该系统进行规范管理的患者,在各方面取得了显著改善。
多家医院反馈,该系统有效提升了慢性肾病患者的管理效率,减轻了医护人员工作负担,促进了医疗资源的优化配置。
响应国家战略,推动分级诊疗
慢性肾脏病是重大的公共卫生问题,中国成年人慢性肾脏病患病率约为10.8%,患者总数超过1.2亿,但知晓率仅为12.5%。由于早期症状不明显,很多患者确诊时已发展到中晚期,错过了最佳治疗时机。
凯德尼医疗创始人兼CEO陈绪勇博士表示:"入选国家级慢性病防治典型数字产品目录,是对我们团队多年努力的肯定,也是对产品专业性和实用性的认可。这份荣誉不仅属于凯德尼,更属于每一位信任和支持我们的患者和医生。"
"慢性肾病的防治需要长期、系统的健康管理,数字技术为解决这一难题提供了新的可能。我们的目标是通过数字化手段,让优质医疗资源下沉到基层,让每一位肾病患者都能获得规范、专业的健康管理服务,从根本上改善慢性肾病的防治现状。"陈绪勇博士补充道。
推广应用,惠及更多患者
根据中国疾控中心和中国信通院的规划,入选展示目录的产品和服务将在全国慢性病综合防控示范区进行重点推广应用。这意味着凯德尼慢性肾脏病全病程管理系统将有机会服务更广泛的患者群体,在更多地区发挥作用。
凯德尼医疗表示,公司将以此次入选为契机,持续优化产品功能,提升服务质量,积极配合各地卫生健康部门和疾控机构,推动系统在基层医疗机构和社区的落地应用,为实现"健康中国2030"战略目标贡献力量。
同时,公司将继续加大研发投入,探索人工智能、5G、物联网等前沿技术在慢性肾病管理中的应用,推动数字疗法的临床研究和监管报批,打造更加智能、精准、便捷的慢性病管理解决方案。
数字赋能,开启慢病管理新时代
此次入选《慢性病防治典型数字产品(服务)目录(2022年)》展示目录,是凯德尼医疗在数字医疗领域取得的又一重要成果,也是中国慢性肾病数字化管理发展的重要里程碑。
在国家大力推动数字健康发展的背景下,以凯德尼为代表的数字医疗企业正在用科技创新改变传统医疗服务模式,为慢性病患者带来更加优质、便捷、可及的健康管理服务。
未来,随着5G、人工智能、大数据等技术的深入应用,数字疗法将在慢性病防治中发挥越来越重要的作用,为提升全民健康水平、实现"健康中国"战略目标提供有力支撑。
关于《慢性病防治典型数字产品(服务)目录(2022年)》
《慢性病防治典型数字产品(服务)目录(2022年)》是由国家卫生健康委员会、工业和信息化部指导,中国疾病预防控制中心慢性非传染性疾病预防控制中心和中国信息通信研究院联合组织编制的首批国家级慢性病防治数字产品权威目录。
目录旨在规范和引导慢性病数字产品与服务的发展,推动优秀产品在全国慢性病综合防控示范区的推广应用,促进数字技术与慢性病防治工作的深度融合,助力健康中国建设。
KidneyTec Product Receives National-Level Recognition, Advancing Digital Prevention and Treatment of Chronic Kidney Disease
In January 2023, the China CDC Center for Chronic and Non-communicable Disease Control and Prevention, together with the China Academy of Information and Communications Technology, jointly released the "Typical Digital Products (Services) for Chronic Disease Prevention and Treatment Directory (2022)". The "KidneyTec Chronic Kidney Disease Full-Process Management System and Digital Therapeutics" independently developed by Beijing KidneyTec Medical Technology Co., Ltd. was successfully selected for the Exhibition Directory, becoming a representative digital product in the field of kidney disease management and receiving national-level authoritative recognition.
Rigorous Review and Multi-Stage Selection
This selection activity was guided by the National Health Commission and the Ministry of Industry and Information Technology, and jointly organized and implemented by the China CDC Center for Chronic and Non-communicable Disease Control and Prevention and the China Academy of Information and Communications Technology. This is the first batch of authoritative selection of national-level digital products and services for chronic disease prevention and treatment.
The selection process lasted several months and went through multiple rigorous stages including formal review, online preliminary evaluation, online defense, technical testing, expert evaluation, on-site inspection, and public satisfaction surveys. Ultimately, 206 products and services were selected from numerous applications nationwide, with 82 products and services selected for the "Exhibition Directory" and 124 selected for the "Shortlisted Directory".
The fact that KidneyTec's Chronic Kidney Disease Full-Process Management System stood out among numerous competitors and entered the Exhibition Directory fully demonstrates the product's comprehensive advantages in multiple dimensions including technological innovation, clinical application, and user satisfaction.
Full-Process Management, Technology Empowering Kidney Disease Prevention
The "KidneyTec Chronic Kidney Disease Full-Process Management System and Digital Therapeutics" is a smart healthcare solution based on internet, big data, and artificial intelligence technology, covering the full-process management stages of chronic kidney disease screening, diagnosis, treatment, rehabilitation, and follow-up.
The system adopts evidence-based medical concepts, with all management plans and health recommendations based on authoritative domestic and international clinical guidelines and latest research findings, ensuring the professionalism and scientific validity of medical services.
Clinical Validation with Significant Results
Since its launch, the KidneyTec Chronic Kidney Disease Full-Process Management System has been applied in numerous tertiary hospitals and primary healthcare institutions nationwide, serving over 2 million chronic kidney disease patients and accumulating rich clinical application experience and real-world data.
Multiple hospitals have reported that the system effectively improves chronic kidney disease patient management efficiency, reduces healthcare worker burden, and promotes optimal allocation of medical resources.
Responding to National Strategy, Promoting Hierarchical Diagnosis and Treatment
Chronic kidney disease is a major public health issue. The prevalence rate of chronic kidney disease among Chinese adults is approximately 10.8%, with a total patient population exceeding 120 million, but awareness rate is only 12.5%. Due to inconspicuous early symptoms, many patients are already in middle to late stages when diagnosed, missing the optimal treatment window.
Dr. Chen Xuyong, Founder and CEO of KidneyTec Healthcare, stated: "Being selected for the national-level Typical Digital Products for Chronic Disease Prevention Directory is recognition of our team's years of effort and validation of our product's professionalism and practicality. This honor belongs not only to KidneyTec but to every patient and doctor who trusts and supports us."
"Prevention and treatment of chronic kidney disease requires long-term, systematic health management, and digital technology provides new possibilities for solving this challenge. Our goal is to use digital means to bring quality medical resources to the grassroots level, enabling every kidney disease patient to access standardized, professional health management services, fundamentally improving the prevention and treatment status of chronic kidney disease," Dr. Chen Xuyong added.
Promotion and Application to Benefit More Patients
According to plans by China CDC and CAICT, products and services selected for the Exhibition Directory will be promoted for key application in national chronic disease comprehensive prevention and control demonstration zones. This means the KidneyTec Chronic Kidney Disease Full-Process Management System will have the opportunity to serve a broader patient population and play a role in more regions.
KidneyTec Healthcare stated that the company will use this selection as an opportunity to continuously optimize product functions, improve service quality, and actively cooperate with local health departments and disease control institutions to promote system implementation in primary healthcare institutions and communities, contributing to achieving the "Healthy China 2030" strategic goals.
At the same time, the company will continue to increase R&D investment, explore the application of cutting-edge technologies such as artificial intelligence, 5G, and IoT in chronic kidney disease management, advance clinical research and regulatory approval of digital therapeutics, and create more intelligent, precise, and convenient chronic disease management solutions.
Digital Empowerment, Opening a New Era of Chronic Disease Management
This selection for the "Typical Digital Products (Services) for Chronic Disease Prevention and Treatment Directory (2022)" Exhibition Directory is another important achievement for KidneyTec Healthcare in the digital medical field and an important milestone in the development of digital chronic kidney disease management in China.
Against the backdrop of the nation's vigorous promotion of digital health development, digital medical enterprises represented by KidneyTec are using technological innovation to transform traditional medical service models, bringing more quality, convenient, and accessible health management services to chronic disease patients.
In the future, with the deep application of technologies such as 5G, artificial intelligence, and big data, digital therapeutics will play an increasingly important role in chronic disease prevention and treatment, providing strong support for improving national health levels and achieving "Healthy China" strategic goals.
About the "Typical Digital Products (Services) for Chronic Disease Prevention and Treatment Directory (2022)"
The "Typical Digital Products (Services) for Chronic Disease Prevention and Treatment Directory (2022)" is the first batch of national-level authoritative directory of digital products for chronic disease prevention and treatment, jointly organized and compiled by the China CDC Center for Chronic and Non-communicable Disease Control and Prevention and the China Academy of Information and Communications Technology, under the guidance of the National Health Commission and the Ministry of Industry and Information Technology.
The directory aims to standardize and guide the development of digital products and services for chronic disease prevention, promote the application of excellent products in national chronic disease comprehensive prevention and control demonstration zones, promote deep integration of digital technology with chronic disease prevention and treatment work, and assist in building a Healthy China.